Results 61 to 70 of about 471 (127)
What do We Know so Far about Ges Carbapenemases, and What Threat do They Pose?
Carbapenemases, classified as bacterial enzymes, have the ability to hydrolyze carbapenems – important broad-spectrum antibiotics. This work attempts to summarize the information on the diversity of Guiana Extended-Spectrum (GES) subgroup of ...
Rutkowski Kamil +6 more
doaj +1 more source
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives
Purpose of review Serious infections caused by nonfermenting Gram-negative bacteria (NF-GNB) pose a significant challenge for clinicians due to the limited treatment options available, which are frequently associated with issues of toxicity and ...
Daniele Roberto Giacobbe +9 more
core +1 more source
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions [PDF]
[Abstract] Objectives: To analyse the impact of the most clinically relevant β-lactamases and their interplay with low outer membrane permeability on the activity of cefiderocol, ceftazidime/avibactam, aztreonam/avibactam, cefepime/enmetazobactam ...
Beceiro, Alejandro +15 more
core +2 more sources
P20 Evaluation of cefepime/enmetazobactam against MDR Enterobacterales [PDF]
Abstract Background Cefepime/enmetazobactam is a fourth generation cephalosporin in combination with a novel penicillanic acid sulfone ESBL inhibitor. Cefepime is stable to AmpC β-lactamases (class C) and OXA-48-like carbapenemases (class D) whilst enmetazobactam has activity against most class A β ...
Richards, J R, Wooton, M, Ward, J R
europepmc +2 more sources
Background: Piperacillin/tazobactam has limited activity against Enterobacterales, which concurrently express ESBL/ampC/OXA-1 beta-lactamases, which are widely prevalent in India.
Yamuna Devi Bakthavatchalam +11 more
doaj +1 more source
Objective: This analysis aimed to provide a mechanistic understanding and an evaluation of the clinical relevance of pharmacokinetic drug-drug interactions (DDIs) associated with drugs approved by the Food and Drug Administration in 2024.
Jingjing Yu, MD, PhD +4 more
doaj +1 more source
The relative inhibitory activities of diazabicyclooctanes (avibactam, relebactam, zidebactam, nacubactam, durlobactam), boronic acid derivatives (vaborbactam, taniborbactam, xeruborbactam), and penicillin-based sulfone derivative enmetazobactam were ...
Le Terrier, Christophe +4 more
core +1 more source
Objectives Carbapenem-resistant Enterobacterales have emerged as a major global health concern owing to their rapid dissemination and limited therapeutic options.
Farah Al-Marzooq +4 more
doaj +1 more source
Abstract Expression of β-lactamases is the primary form of β-lactam antibiotic resistance in Gram-negative bacteria. Enmetazobactam is a penicillanic acid sulfone (PAS) that inhibits extended spectrum β-lactamases (ESBLs) by forming an acyl-enzyme complex that eventually breaks down to an irreversible lysinoalanine ...
Beer M +10 more
europepmc +2 more sources
Abstract Background Cefepime/enmetazobactam (FEP/META) is a new β-lactam/β-lactamase inhibitor combination with broad-spectrum activity against MDR Enterobacterales (including OXA-48-producing isolates) which has demonstrated superiority to piperacillin/tazobactam for the treatment of complicated ...
Ward, Jon +4 more
openaire +1 more source

